The Korean Journal of Food & Health Convergence (식품보건융합연구)

Korea Food & Health Convergence Association (한국식품보건융합학회)
권호 표지
DOI QR코드

DOI QR Code

Anti-hyperlipidemic Effect of Vitex doniana Ethanol Extract in Poloxamer Induced Hyperlipidemia

  • Received : 2018.09.20
  • Accepted : 2018.11.17
  • Published : 2018.12.30
Download PDF
⟨ Previous Next ⟩

Abstract

To determine the effect of Vitex doniana (leaves stem and root bark) ethanolic extracts on lipid profiles of Poloxamer 407 (P407) induced hyperlipidemic and normal rats. Fifty four mixed sex rats weighing 100-200g were divided into nine groups comprising six animals per group. At the end of the 21 day, the animals were sacrificed and blood sample were collected for determination of serum levels of: Total cholesterol (TC), Triacylglycerides (TAG), High-density lipoprotein cholesterol (HDL-c) and Low-density lipoprotein cholesterol (LDL-c). The studies showed that all induced treated groups significantly (P<0.05) lower serum levels of TC, TAG, LDL-c and significantly (P<0.05) increased HDL-c when compared to the P407 induced hyperlipidemic control. The normal treated groups showed no significant (P>0.05) difference in the serum levels of TC, TAG, LDL and HDL when compared to the normal control group. Calculation of atherogenic risk predictor indices of the induced treated groups showed that all the extracts significantly (P<0.05) lowered the LDL-c/HDL-c, log (TAG/HDL-c) and significantly (P<0.05) increased HDL-c/TC ratio when compared to the P407 induced hyperlipidemic control group. The atherogenic risk predictor indices of normal treated groups showed no significant difference (P>0.05) in LDL-c/HDL-c, Log (TAG/HDL-c) and HDL-c/TC ratio when compared to the normal control group. The study demonstrates the phytotherapeutic effect of Vitex doniana (leaves, stem and root bark) ethanolic extract in poloxamer 407 induced hyperlipidemia.

Keywords

References

  1. Abdulazeez, M. (2011). Effect of Peristrophe bicalyculata on lipid profile of P- 407-induced hyperlipidemic Wistar rats. J. of Med. Plants Res., 5(4), 490-494.
  2. Akoh, C.C. (2005). Handbook of Functional Lipids. Boca Raton, FL: CRC Press.
  3. Baum, J.A., Teng, H., Erdman, J.W., Weigel, R.M., Klein, B.P., Persky, V.W., Freels, S., Surya, P., Bakhit, R.M., Ramos, E., Shay, N.F., & Potter, S.M. (1998). Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. American J. of Clin. Nutr., 68(3), 545-551. https://doi.org/10.1093/ajcn/68.3.545
  4. Beckmann, N., Cannet, C., Babib, A.L., Bie, F.X., Zurbruegg, S., Kneuer, R., & Dousset, V. (2009). In vivo visualization of macrophage infiltration and activity in inflammation using magnetic resonance imaging. Nanomed. and Nanobiotech, 1(3), 272-298. https://doi.org/10.1002/wnan.16
  5. Brown, S.L. (1996). Lowered serum cholesterol and low mood. Brit. J. of med, 313, 637-638. https://doi.org/10.1136/bmj.313.7058.637
  6. Davey, S.G. (1993). Cholesterol lowering and mortality: the importance of considering initial level of risk. Int. Med. J., 306, 1367-1373.
  7. Davey, S.G., & Pekkanen, J. (1992). Should there be a moratorium on the use of cholesterol lowering drugs? Br. Med J., 304, 431-440. https://doi.org/10.1136/bmj.304.6824.431
  8. Dobiasova, M. (2006). AIP-atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice. Vnitrni Lekarstvi, 52(1), 64-71.
  9. Dobiasova, M., & Frohlich, J. (2001). The plasma parameter Log (TG/HDLC) as an atherogenic index: correlation with lipoprotein particle size and etherification rate in apoB-lipoprotein-depleted plasma (FERHDL). J. of Clin. Biochem., 12, 588-592.
  10. Dobiavosa, M., Urbanova, Z., & Samanek, M. (2005). Relation between particle size of HDL and LDL Lipoproteins and cholesterol Esterification rate. Physiol. Res., 54, 159-165.
  11. Duke, J.A. (1993). Medicinal plants and the pharmaceutical industry. In J. Janick & J.E. Simon, New Crops (pp. 664-669). Wiley, NY: John Wiley & Sons Ltd.
  12. Dumortier, G., Grossiord, J.L., Agnely, F., & Chaumeil, J.C. (2006). A review of poloxamer 407 pharmaceutical and pharmacological Characteristics. Pharmace. Res., 23(12), 2709-2728. https://doi.org/10.1007/s11095-006-9104-4
  13. F.A.O. (1983). Food and fruit bearing forest species: Examples from Eastern Africa.
  14. Friedewald, W.T. (1972). Methods for the determination of LDL Cholesterol. Clin. Chem., 18, 499-502.
  15. Geetha, G., Kalavalarasariel, G.P., & Sankar, V. (2011). Antidiabetic effect of Achyranthesrubrofusca leaf extracts on alloxan induced diabetic rats. Pak J. of Pharmace. Sci., 24(2), 193-199.
  16. Grundy, S.M. (1986). Cholesterol and coronary heart disease: a new era. J.Am. Med. Assoc., 256, 2849-2858. https://doi.org/10.1001/jama.1986.03380200087027
  17. Johnston, T.P. (2004). The P-407-induced murine model of dose-controlled hyperlipidemia and atherosclerosis: A review of findings to date. J. Cardiovasc. Pharmacol., 43(4), 595-606. https://doi.org/10.1097/00005344-200404000-00016
  18. Johnston, T.P., Punjabiand, M.A., & Froelich, C.J. (1992). Sustained delivery of interleukin-2 from a poloxamer- 407 gel matrix following intraperitoneal injection in mice. Pharm. Res., 9, 425-434. https://doi.org/10.1023/A:1015815624334
  19. Kaesancini, A.Y., & Krauss, R.M. (1994). Cardio vascular disease and hyperlipidemia. Cur. Opinion in lipidolo., 5, 249-251. https://doi.org/10.1097/00041433-199408000-00001
  20. Karmarkar, B. (2008). Poloxamers and their applications. Pharmacy Student Articles. Retrieved 15 February, 2012 from http://www.pharmainfo.net.
  21. Kastelein, J.J.P., van der Steeg, W.A., Holme, L., Gaffney, M., CaterBarter, N.B., Deedwania, P., Olsson, A.G., Boekholdt, S.M., Demicco, D.A., Szarek, M., LaRosa, J.C., Pedersen, T.R., Grundy, S.M., & IDEAL study Groups. (2008). Lipids apolipoproteins and their ratios in relation to cardiovascular events with statin treatment. Circul. 117(23), 3002-3009 https://doi.org/10.1161/CIRCULATIONAHA.107.713438
  22. Kim, H., Jeong, D., Jung, H., Yokozawaand, T., & Choi, J. (2008). Hypolipidemic Effects of Sophoraflavescens and Its Constituents in Poloxamer 407- Induced Hyperlipidemic and Cholesterol-Fed Rats. Biolo. and Pharmace. Bulletin., 31(1), 73-78.
  23. Kumar, S., Kumar, R., & Khan, A. (2011). Medicinal Plant Resources: Manifestation and Prospects of Life sustaining Healthcare System. Conti. J. of Biolo. Sci., 4 (1), 19-29.
  24. Lorke, D. (1983). A new approach to practical acute toxicity testing. Archiv. of Toxicol., 54(4), 275-287. https://doi.org/10.1007/BF01234480
  25. Mahmood, Z.A., Mohammad, S., Mahmood, S.B.Z., & Karim, M.A. (2010). Herbal treatment for cardiovascular disease the evidence based therapy. Pak. J. of Pharmace. Sci., 23(1), 119-124.
  26. Megalli, S., Aktan, F., Daviesand, N.M., & Roufogalis, B.D. (2005). Phytopreventative anti-hyperlipidemic effects of Gynostemma pentaphyllum in rats. J. Pharm. Set., 8(3), 507-15.
  27. Messina, M.J. (1999). Legumes and soybeans: Overview of their nutritional profiles and health effects. Am. J. Clin. Nutr., 70(3), 439-450. https://doi.org/10.1093/ajcn/70.4.439
  28. Murphy, S.A., Cannon, C.P., & Braunwald, E. (2007). Effect of intensive lipid lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction (22 trials). The Ame. J. of Cardio., 100(7), 1047-1051. https://doi.org/10.1016/j.amjcard.2007.04.053
  29. Nicholls, S.J., Tuzcu, E.M., & Sipahi, I. (2007). Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. J. of the Ame. Med. Assoc., 297(5), 499-508. https://doi.org/10.1001/jama.297.5.499
  30. Nissen, S.E., Tuzcu, E.M., & Brodie, B. (2004). Effect of intensive compared with moderate lipid lowering therapy on progression of coronary atherosclerosis. J. of the Ame.Med. Assoc., 291(9), 1071-1080. https://doi.org/10.1001/jama.291.9.1071
  31. Ojiakor, A., & Nwanjo, H. (2005). Effect of vitamine E and C on exercise induced oxidative stress. Global J. of Pure Applied Sci., 12(2), 199-202.
  32. Oluyemi, K.A., Omotuyi, I.O., Jimoh, O.R., Adesanya, O.A., Saalu, C.L., & Josiah, S.J. (2007). Erythropoietic and anti-obesity effects of Garcinia cambogia (bitter kola) in Wistar rats. Biotechnol. Appl. Bioc., 46, 69-72. https://doi.org/10.1042/BA20060105
  33. Poss, J., Custodis, F., Werner, C. & Laufs, U. (2011). Cardiovascular disease and dyslipidemia: Beyond LDL. Curr. Pharmaceu. Design., 17(9), 861-870. https://doi.org/10.2174/138161211795428858
  34. Quideau, S., Deffieux, D., Douat‐Casassus, C., & Pouysegu, L. (2011). Plant polyphenols: chemical properties, biological activities, and synthesis. Angewandte Chemie International Edition, 50(3), 586-621. https://doi.org/10.1002/anie.201000044
  35. Rohman, A., Riyanto, S., Yuniarti, N., Saputra, W.R., Utami, R., & Mulatsih, W. (2010). Antioxidant activity, total phenolic, and total flavaonoid of extractsand fractions of red fruit (Pandanus conoideus Lam). Internat. Food Res. J., 17, 97-106.
  36. Saravanan, N., Rajendra, P., & Pugalandi, K.V. (2003). Effect of Piper betle leaf extract on alcoholic toxicity in the rat brain. J.Med.Food, 6, 261-265. https://doi.org/10.1089/10966200360716689
  37. Sikarwar, M.S., & Patil, M.B. (2011). Antihyperlipidemic Effect of Ethanolic Extract of Hibiscus rosa sinensis Flowers in Hyperlipidemic Rats. RGUHS J. of Pharmaceu. Sci., 1(2), 117-122.
  38. Sofowora, E.A. (1993). Medicinal plants and traditional medicine in Africa. Chicago, IL: University of Illinois.
  39. Stein, E.A. (1987). Lipids, lipoproteins and apolipoproteins. In N.W. Tietz, Textbook of Clinical Chemistry (pp. 829-900). Philadelphia, PA: Saunders.
  40. Steinleitner, A., Lambert, H., Kazensky, C., & Cantor, B. (1991). Poloxamer-407 as an intraperitoneal barrier material for the prevention of postsurgical adhesion formation and reformation in rodent models for reproductive surgery. Obstet. Gynecol., 77, 48-52.
  41. Vaziri, N.D., & Morris, K. (2011). Lipid disorders and their relevance to outcomes in chronic kidney disease. Blood Purification, 31(1-3), 189-196. https://doi.org/10.1159/000321845
  42. Yokozawa, T., Cho, E.J., & Sasaki, S. (2006). The protective role of Chinese prescription kangen-karyu extract on diet- induced hypercholesterolemia in rats. Biological and Pharmaceutical Bulletin, 29, 760-765. https://doi.org/10.1248/bpb.29.760